Enochian Presents at World Vaccine Conference on Promising Human & Laboratory Data to Potentially Treat Solid Tumors

Read More

If We Want The Pandemic To End, CEOs Need To Do What Governments Won't...

By Mark Dybul & Serhat Gumrukcu | This Article Originally Appeared on Fortune

Link to Article

Groundbreaking Science that transforms the life of patients

One audacious mission to use groundbreaking science for cures and effective prevention of infectious diseases and cancer.

call to action

Enochian / Eno-key-in

Enochian BioSciences is a biopharmaceutical company dedicated to identifying, developing, manufacturing, and commercializing gene-modified cell therapy. Our gene-modified cell therapy platform can be applied to multiple indications including HIV/AIDS and Oncology.

Our Objectives



HIV Preventative Vaccine and Cures

HBV Treatment or Cure

Cellular Immune-oncology Products

Focused for the prevention of relapse of metastatic colon cancer after resection and chemotherapy

Genetically-modified Dendritic Cell Platform for Treatment of Cancer

Why Do We Need a Cure and a Vaccine for HIV?


0 Living with HIV Worldwide in 2017

0 Infected with HIV Worldwide in 2017

0 AIDS Related Deaths Worldwide in 2017

0 Diagnosed with HIV in the U.S. in 2017

"It is so important to find a cure for HIV, so many people are affected and would benefit. We need companies like Enochian BioSciences to pursue this very important goal." -Hans Peter Kiem